Plasma-soluble CD40 is related to cholesterol metabolism in patients with moderate hypercholesterolemia

Scandinavian Cardiovascular Journal

Volumn 40, Issue 5, 2006, Pages 280-284

  Luomala, Mari ^a,b   Päivä, Hannu ^a   Laaksonen, Reijo ^a,b   Thelen, Karin ^c   Lütjohann, Dieter ^c   Peltonen, Nina ^a,b   Lehtimäki, Terho ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

CD40; Cholesterol; Metabolism

Indexed keywords

26 HYDROXYCHOLESTEROL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ATORVASTATIN; BIOLOGICAL MARKER; CAMPESTEROL; CD40 ANTIGEN; CHOLESTEROL; LATHOSTEROL; PLACEBO; SIMVASTATIN; SITOSTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CELL LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GAS LIQUID CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNITY; IMMUNOREACTIVITY; LINEAR REGRESSION ANALYSIS; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; UPREGULATION;

ANTICHOLESTEREMIC AGENTS; ANTIGENS, CD40; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, DIETARY; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; PYRROLES; SEVERITY OF ILLNESS INDEX; SIMVASTATIN; SOLUBILITY;

EID: 33749393298     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430600959978     Document Type: Article

References (23)

1. Erl, W and Weber, PC and Weber, C. (1998) Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands Atherosclerosis, 136, pp. 297-303.
2. Schonbeck, U and Libby, P. (2001) CD40 signaling and plaque instability Circ Res, 89, pp. 1092-103.
3. Lutgens, E and Gorelik, L and Daemen, MJ and de Muinck, ED and Grewal, IS and Koteliansky, VE and (1999) Requirement for CD154 in the progression of atherosclerosis Nat Med, 5, pp. 1313-6.
4. Mach, F and Schonbeck, U and Sukhova, GK and Bourcier, T and Bonnefoy, JY and Pober, JS and (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis Proc Natl Acad Sci USA, 94, pp. 1931-6.
5. Simonen, PP and Gylling, HK and Miettinen, TA. (2002) Diabetes contributes to cholesterol metabolism regardless of obesity Diabetes Care, 25, pp. 1511-5.
6. Bjorkhem, I and Diczfalusy, U. (2002) Oxysterols: Friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol, 22, pp. 734-42.
7. Paiva, H and Thelen, KM and Van Coster, R and Smet, J and De Paepe, B and Mattila, KM and (2005) High-dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial Clin Pharmacol Ther, 78, pp. 60-8.
8. Tone, M and Tone, Y and Fairchild, PJ and Wykes, M and Waldmann, H. (2001) Regulation of CD40 function by its isoforms generated through alternative splicing Proc Natl Acad Sci USA, 98, pp. 1751-6.
9. Contin, C and Pitard, V and Itai, T and Nagata, S and Moreau, JF and Dechanet-Merville, J. (2003) Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling J Biol Chem, 278, pp. 32801-9.
10. De Paoli, P and Cozzi, M and Tedeschi, R and Gloghini, A and Cilia, AM and van Kooten, C and (1997) High CD40 membrane expression in AIDS-related lymphoma B cell lines is associated with the CD45RA+, CD45RO+, CD95+ phenotype and high levels of its soluble form in culture supernatants Cytometry, 30, pp. 33-8.
11. Garcia-Cruset, S and Carpenter, KL and Guardiola, F and Stein, BK and Mitchinson, MJ. (2001) Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions Free Radic Res, 35, pp. 31-41.
12. Babiker, A and Andersson, O and Lund, E and Xiu, RJ and Deeb, S and Reshef, A and (1997) Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport J Biol Chem, 272, pp. 26253-61.
13. Harik-Khan, R and Holmes, RP. (1990) Estimation of 26-hydroxycholesterol in serum by high-performance liquid chromatography and its measurement in patients with atherosclerosis J Steroid Biochem, 36, pp. 351-5.
14. Lee, WL and Lee, WJ and Chen, YT and Liu, TJ and Liang, KW and Ting, CT and (2006) The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease Metabolism, 55, pp. 1029-34.
15. Cipollone, F and Mezzetti, A and Porreca, E and Di Febbo, C and Nutini, M and Fazia, M and (2002) Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: Effects of statin therapy Circulation, 106, pp. 399-402.
16. Wang, TD and Chen, WJ and Lin, JW and Cheng, CC and Chen, MF and Lee, YT. (2003) Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: Relations with baseline lipid profiles Atherosclerosis, 170, pp. 315-23.
17. Schonbeck, U and Gerdes, N and Varo, N and Reynolds, RS and Horton, DB and Bavendiek, U and (2002) Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells Circulation, 106, pp. 2888-93.
18. Mulhaupt, F and Matter, CM and Kwak, BR and Pelli, G and Veillard, NR and Burger, F and (2003) Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells Cardiovasc Res, 59, pp. 755-66.
19. Garlichs, CD and John, S and Schmeisser, A and Eskafi, S and Stumpf, C and Karl, M and (2001) Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia Circulation, 104, pp. 2395-400.
20. Li, Y and Schwabe, RF and DeVries-Seimon, T and Yao, PM and Gerbod-Giannone, MC and Tall, AR and (2005) Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: Model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis J Biol Chem, 280, pp. 21763-72.
21. Montero, MT and Hernandez, O and Suarez, Y and Matilla, J and Ferruelo, AJ and Martinez-Botas, J and (2000) Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells Atherosclerosis, 153, pp. 303-13.
22. TakahashiHK, MoriS, IwagakiH, YoshinoT, TanakaN, Weitz-SchmidtG,. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes. J Leukoc Biol. 2004;77:400-7.
23. SeungHH, KohKK, QuonMJ, LeeY, ShinEK. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients. Atherosclerosis. 2006. Article in press